Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,047 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating an interactive acceptance and commitment therapy (ACT) workshop delivered to trained therapists working with cancer patients in the United Kingdom: a mixed methods approach.
Moschopoulou E, Brewin D, Ridge D, Donovan S, Taylor SJC, Bourke L, Eva G, Khan I, Chalder T; SURECAN Grant Investigators. Moschopoulou E, et al. Among authors: khan i. BMC Cancer. 2022 Jun 13;22(1):651. doi: 10.1186/s12885-022-09745-4. BMC Cancer. 2022. PMID: 35698089 Free PMC article.
A meta-ethnography investigating relational influences on mental health and cancer-related health care interventions for racially minoritised people in the UK.
Ridge D, Pilkington K, Donovan S, Moschopoulou E, Gopal D, Bhui K, Chalder T, Khan I, Korszun A, Taylor S; SURECAN Investigators. Ridge D, et al. Among authors: khan i. PLoS One. 2023 May 10;18(5):e0284878. doi: 10.1371/journal.pone.0284878. eCollection 2023. PLoS One. 2023. PMID: 37163472 Free PMC article.
Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial.
Khan I, Taylor SJC, Robinson C, Moschopoulou E, McCrone P, Bourke L, Thaha M, Bhui K, Rosario D, Ridge D, Donovan S, Korszun A, Little P, Morgan A, Quentin O, Roylance R, White P, Chalder T. Khan I, et al. Trials. 2024 Apr 2;25(1):228. doi: 10.1186/s13063-024-08062-4. Trials. 2024. PMID: 38566197 Free PMC article. Clinical Trial.
A phase 3 non-inferiority trial of locally manufactured Meningococcal ACWY vaccine 'Ingovax ACWY' among Bangladeshi adults.
Ahmed T, Tauheed I, Hoque S, Sarower Bhuyan G, Biswas R, Tarikul Islam M, Islam S, Amir Hossain M, Ahmmed F, Muktadir A, Muktadir H, Ahmed F, Karim M, Panday AS, Kundu Tanu T, Muktadir Rahman Ashik M, Rahad Hossain M, Shariful Bari S, Ahmed R, Masudur Rahman Mia M, Islam S, Khan I, Mainul Ahasan M, Chowdhury F, Rahman Bhuiyan T, Islam Chowdhury M, Qadri F. Ahmed T, et al. Among authors: khan i. Vaccine. 2024 Jun 18:S0264-410X(24)00704-7. doi: 10.1016/j.vaccine.2024.06.030. Online ahead of print. Vaccine. 2024. PMID: 38897895
Predictive Nomogram and Propensity Score Matching in Neuroendocrine Carcinoma of the Tubular Gastrointestinal Tract: A US Population-Based Clinical Outcome Study.
Yasinzai AQK, Khan M, Chandasir A, Olavarria-Bernal D, Sohail AH, Wali A, Tareen B, Nguyen T, Fox AD, Goyal A, Khan I, Waheed A, Iqbal A, Karki NR, Das K, Ullah A. Yasinzai AQK, et al. Among authors: khan i. Cancers (Basel). 2024 May 24;16(11):1998. doi: 10.3390/cancers16111998. Cancers (Basel). 2024. PMID: 38893117 Free PMC article.
6,047 results